Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Schifano F, Catalani V, Sharif S, et al. Benefits and harms of “smart drugs” (nootropics) in healthy individuals. Drugs. 2022;82(6):633–47.
2. Carton L, Cabé N, Ménard O, et al. Pharmaceutical cognitive doping in students: a chimeric way to get-a-head? Therapie. 2018;73(4):331–9.
3. Zaami S, Rinaldi R, Bersani G, et al. Nootropics use in the workplace: psychiatric and ethical aftermath towards the new frontier of bioengineering. Eur Rev Med Pharmacol Sci. 2020;24(4):2129–39.
4. Jaha R, Kolak T, Helać H, et al. Smartdrugs: mechanisms of action and ethical issues. In: Badnjevic A, GurbetaPokvić L (eds). CMBEBIH 2021. IFMBE Proceedings, Vol 84. Cham: Springer; 2021. pp 462–468.
5. Mohamed A, Sahakian B. The ethics of elective psychopharmacology. Int J Neuropsychopharmacol. 2012;15(4):559–71.